Back

Paralogous lncRNAs CYTOR and MORRBID share a conserved trans acting function in MEK ERK signaling

Ali-Nasser, T.; Khoury, C.; Altalef Mishaan, S.; Bhonkar, O.; Lin, Z.; Qian, Y.; Lahoud-Jeries, N. L.-J.; Aran, D.; Bester, A. C.

2026-06-29 genetics
10.64898/2026.06.24.734157 bioRxiv
Show abstract

Background: Long non-coding RNAs (lncRNAs) exhibit rapid evolutionary turnover, often driven by genomic duplication. How paralogous lncRNAs maintain, partition, or diverge in function across distinct genomic contexts remains poorly understood. The evolutionarily conserved lncRNA MORRBID and its primate-specific paralog CYTOR provide a natural framework to interrogate the functional consequences of lncRNA duplication. Results: Although CYTOR and MORRBID have acquired distinct transcript variants influenced by their divergent genomic environments, we demonstrate that they maintain a robust, shared core function encoded by near-identical dominant two-exon transcripts. Using SNP-based paralog-specific quantification, we found that CYTOR contributes more strongly to the shared transcript pool, while both transcripts localize predominantly to the cytoplasm, consistent with a shared trans-acting function. Simultaneous repression of CYTOR and MORRBID consistently impairs cell adhesion and migration across multiple cancer models. Mechanistically, the shared CYTOR/MORRBID transcript pool associates with MEK2 and sustains MEK-ERK signaling. This signaling axis promotes FOSL1 expression and AP-1-linked transcriptional output, including expression of the downstream effector EPHA4, whose role was supported by rescue experiments. Patient tumor transcriptomes and healthy single-cell datasets further supported the associated mesenchymal, adhesion, and epithelial-mesenchymal transition program. Conclusions: Our findings establish that paralogous lncRNAs can retain a conserved mechanistic core despite context-dependent transcriptional divergence. The CYTOR/MORRBID transcript pool defines a shared lncRNA signaling module that supports MAPK-ERK signaling and adhesion-migration programs across cancer and mesenchymal-like cellular contexts. This defines a unified mechanistic framework for the shared core function of these widely studied paralogous lncRNAs.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 16%
11.6%
2
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 3%
10.4%
3
PLOS Genetics
862 papers in training set
Top 1%
9.4%
4
eLife
5828 papers in training set
Top 17%
6.6%
5
Genome Biology
637 papers in training set
Top 2%
6.1%
6
RNA
189 papers in training set
Top 0.4%
5.4%
7
Genome Research
468 papers in training set
Top 2%
3.9%
50% of probability mass above
8
Cell Reports
1498 papers in training set
Top 13%
3.1%
9
Scientific Reports
3612 papers in training set
Top 37%
3.1%
10
The American Journal of Human Genetics
234 papers in training set
Top 1%
3.0%
11
Nucleic Acids Research
1281 papers in training set
Top 7%
2.4%
12
Genome Medicine
183 papers in training set
Top 2%
2.1%
13
PLOS ONE
5266 papers in training set
Top 47%
1.9%
14
iScience
1154 papers in training set
Top 15%
1.9%
15
Cell Genomics
172 papers in training set
Top 2%
1.9%
16
The EMBO Journal
309 papers in training set
Top 4%
1.6%
17
Genomics, Proteomics & Bioinformatics
16 papers in training set
Top 0.1%
1.4%
18
Journal of Biological Chemistry
690 papers in training set
Top 8%
1.1%
19
Molecular Cell
350 papers in training set
Top 4%
1.1%
20
Communications Biology
993 papers in training set
Top 23%
1.1%
21
BMC Genomics
406 papers in training set
Top 7%
1.0%
22
GENETICS
483 papers in training set
Top 4%
0.9%
23
EMBO Reports
263 papers in training set
Top 8%
0.8%
24
Life Science Alliance
285 papers in training set
Top 8%
0.8%
25
Science Advances
1243 papers in training set
Top 31%
0.8%
26
Frontiers in Genetics
230 papers in training set
Top 7%
0.6%
27
Human Molecular Genetics
141 papers in training set
Top 4%
0.6%
28
BMC Biology
265 papers in training set
Top 7%
0.6%